Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$135,257,185
+$93,990,803 QoQ
Shares Held
1,587,712
+153.6% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#20
of 477 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$51,114
PutShares
600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names. CYTK ranks #2 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
This page
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in CYTK
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,114 | 600 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $135,257,185 | 1,587,712 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $454,779 | 6,900 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $41,266,382 | 626,102 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,845,480 | 28,000 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $1,658,394 | 26,100 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $705,294 | 11,100 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $1,099,200 | 20,000 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $1,648,800 | 30,000 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $25,912,650 | 471,482 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,817,200 | 55,000 | Put | Defined | 2025-08-14 | |
| 2024-12-31 | $7,992,707 | 169,913 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $4,704,000 | 100,000 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $2,112,000 | 40,000 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $24,499,728 | 464,010 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $1,056,000 | 20,000 | Call | Defined | 2024-11-14 | |
| 2024-03-31 | $25,569,747 | 364,709 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $3,330,225 | 47,500 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $41,745,000 | 500,000 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $18,367,800 | 220,000 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | $13,116,279 | 157,100 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,178,400 | 40,000 | Put | Defined | 2023-11-14 | |
| 2023-06-30 | $5,232,248 | 160,400 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $1,550,400 | 32,000 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $771,380 | 19,633 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $59,727,906 | 1,622,600 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $40,358,993 | 885,454 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $36,072,382 | 1,009,300 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,481,225 | 327,500 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,713,196 | 374,600 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $24,235,589 | 1,166,294 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $34,777,477 | 1,606,350 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $7,737,488 | 328,277 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,328,248 | 791,200 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||